相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Overexpression of Forkhead Box M1 Transcription Factor (FOXM1) is a Potential Prognostic Marker and Enhances Chemoresistance for Docetaxel in Gastric Cancer
Kaoru Okada et al.
ANNALS OF SURGICAL ONCOLOGY (2013)
Stage-Stratified Analysis of Prognostic Significance of Tumor Size in Patients with Gastric Cancer
Hongliang Zu et al.
PLOS ONE (2013)
The incidences and mortalities of major cancers in China, 2009
Wanqing Chen et al.
CHINESE JOURNAL OF CANCER (2013)
FoxM1 mediated resistance to gefitinib in non-small-cell lung cancer cells
Nuo Xu et al.
ACTA PHARMACOLOGICA SINICA (2012)
Young age, increased tumor proliferation and FOXM1 expression predict early metastatic relapse only for endocrine-dependent breast cancers
Christina Yau et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
Randomised, non-comparative phase II study of weekly docetaxel with cisplatin and 5-fluorouracil or with capecitabine in oesophagogastric cancer: the AGITG ATTAX trial
N. C. Tebbutt et al.
BRITISH JOURNAL OF CANCER (2010)
FoxM1 Mediates Resistance to Herceptin and Paclitaxel
Janai R. Carr et al.
CANCER RESEARCH (2010)
Critical Role and Regulation of Transcription Factor FoxM1 in Human Gastric Cancer Angiogenesis and Progression
Qiang Li et al.
CANCER RESEARCH (2009)
Hedgehog Target Genes: Mechanisms of Carcinogenesis Induced by Aberrant Hedgehog Signaling Activation
Y. Katoh et al.
CURRENT MOLECULAR MEDICINE (2009)
Expression of FLJ10540 is correlated with aggressiveness of oral cavity squamous cell carcinoma by stimulating cell migration and invasion through increased FOXM1 and MMP-2 activity
C-H Chen et al.
ONCOGENE (2009)
Chemotherapy for metastatic gastric cancer: past, present, and future
Atsushi Ohtsu
JOURNAL OF GASTROENTEROLOGY (2008)
Thiostrepton selectively targets breast cancer cells through inhibition of forkhead box M1 expression
Jimmy M-M. Kwok et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Cost-effectiveness analysis of chemotherapy for advanced gastric cancer in China
Xin-Zu Chen et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2008)
Split-dose docetaxel, cisplatin and leucovorin/fluorouracil as first-line therapy cancer and adenocarcinoma of in advanced gastric the gastroesophageal junction: results of a phase II trial
S. Lorenzen et al.
ANNALS OF ONCOLOGY (2007)
Clinical benefit with docetaxel plus fluorouracil and cisplatin compared with cisplatin and fluorouracil in a phase III trial of advanced gastric or gastroesophageal cancer adenocarcinoma: The V-325 study group
Jaffer A. Ajani et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Quality of life with docetaxel plus cisplatin and fluorouracil compared with cisplatin and fluorouracil from a phase III trial for advanced gastric or gastroesophageal adenocarcinoma: The V-325 study group
Jaffer A. Ajani et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Quality of life in patients with advanced gastric cancer: a randomized trial comparing docetaxel, cisplatin, 5-FU (TCF) with epirubicin, cisplatin, 5-FU (ECF)
Sanambar Sadighi et al.
BMC CANCER (2006)
Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: A report of the V325 study group
Eric Van Cutsem et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
FoxM1B is overexpressed in human glioblastomas and critically regulates the tumorigenicity of glioma cells
MG Liu et al.
CANCER RESEARCH (2006)
Forkhead box m1 regulates the transcriptional network of genes essential for mitotic progression and genes encoding the SCF (Skp2-Cks1) ubiquitin ligase
IC Wang et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
Phase II study of low-dose docetaxel/fluorouracil/cisplatin in metastatic gastric carcinoma
SR Park et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2005)
Docetaxel+5-fluorouracil plus cisplatin 3-day combination chemotherapy as a first-line treatment in patient with unresectable gastric cancer
DY Oh et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2005)
Docetaxel (Taxotere), cisplatin, UFT, and leucovorin combination chemotherapy in advanced gastric cancer
SC Oh et al.
BRITISH JOURNAL OF CANCER (2005)
Mechanisms of Taxol resistance related to microtubules
GA Orr et al.
ONCOGENE (2003)
分享论文
